E-LIB Suche - Ergebnisse für: Schmidinger, K.

1

Halogenzahlen und verwandte Kennzahlen bei Ölen:

Toms, H. ; Eibner, A. ; Schmidinger, K....
Fresenius' Zeitschrift für analytische Chemie; Zeitschrift für analytische Chemie. 77 (1929) 9-10 - p. 382-385 , 1929

Link: https://doi.org/10.1007/..

2

Impact of Prior Cytoreductive Nephrectomy on Efficacy in Pa..:

Grimm, Marc-Oliver ; Oya, Mototsugu ; Choueiri, Toni K....
European Urology. 85 (2024) 1 - p. 8-12 , 2024

Link: https://doi.org/10.1016/..

3

Impact of gender on the efficacy of immune checkpoint inhib..:

Yanagiswawa, T. ; Kawada, T. ; Quhal, F....
European Urology. 83 (2023) - p. S484-S485 , 2023

Link: https://doi.org/10.1016/..

4

Efficacy of avelumab plus axitinib versus sunitinib by numb..:

Tomita, Y. ; Motzer, R.J. ; Choueiri, T.K....
ESMO Open. 8 (2023) 6 - p. 102034 , 2023

Link: https://doi.org/10.1016/..

5

Extended follow-up from JAVELIN Renal 101: subgroup analysi..:

Haanen, J.B.A.G. ; Larkin, J. ; Choueiri, T.K....
ESMO Open. 8 (2023) 3 - p. 101210 , 2023

Link: https://doi.org/10.1016/..

6

Immunotherapy-based combinations in the first-line treatmen..:

Quhal, F. ; Mori, K. ; Laukhtina, E....
European Urology. 81 (2022) - p. S591-S592 , 2022

Link: https://doi.org/10.1016/..

7

First-line immunotherapy-based combinations for metastatic ..:

Quhal, F. ; Mori, K. ; Mostafaei, H....
European Urology. 81 (2022) - p. S593-S594 , 2022

Link: https://doi.org/10.1016/..

8

Pembrolizumab outperforms tyrosine kinase inhibitors in the..:

Laukhtina, E. ; Quhal, F. ; Mori, K....
European Urology. 81 (2022) - p. S1480-S1481 , 2022

Link: https://doi.org/10.1016/..

9

Efficacy and safety of avelumab plus axitinib in elderly pa..:

Tomita, Y. ; Motzer, R.J. ; Choueiri, T.K....
ESMO Open. 7 (2022) 2 - p. 100450 , 2022

Link: https://doi.org/10.1016/..

10

Adjuvant immunotherapy versus tyrosine kinase inhibitors in..:

Laukhtina, E. ; Quhal, F. ; Mori, K....
European Urology Open Science. 33 (2021) - p. S333-S334 , 2021

Link: https://doi.org/10.1016/..

11

Tumor mutational burden and immune infiltrates in renal cel..:

Steindl, A. ; Alpar, D. ; Heller, G....
ESMO Open. 6 (2021) 2 - p. 100057 , 2021

Link: https://doi.org/10.1016/..

12

Analysis by region of outcomes for patients with advanced r..:

Schmidinger, Manuela ; Motzer, Robert J. ; Rolland, Frederic...
Acta Oncologica. 61 (2021) 1 - p. 52-57 , 2021

Link: https://doi.org/10.1080/..

13

Evaluation of a panel of preoperative blood-based systemic ..:

Laukhtina, E. ; Schuettfort, V.M. ; D`andrea, D....
European Urology. 79 (2021) - p. S882 , 2021

Link: https://doi.org/10.1016/..

14

Updated efficacy results from the JAVELIN Renal 101 trial: ..:

Choueiri, T.K. ; Motzer, R.J. ; Rini, B.I....
Annals of Oncology. 31 (2020) 8 - p. 1030-1039 , 2020

Link: https://doi.org/10.1016/..

15

Clinical Outcomes by Nephrectomy Status In METEOR, A Random..:

Tannir, Nizar M. ; Powles, Thomas ; Escudier, Bernard...
Kidney Cancer. 4 (2020) 1 - p. 29-39 , 2020

Link: https://doi.org/10.3233/..